Intercede Group PLC
21 October 2002
INTERCEDE GROUP plc
('Intercede' or 'the Company')
Contract Win
Major telecommunications company to deploy Intercede's edeficeTM digital
identity management system to support managed service customers.
Intercede Group plc, a leading developer of digital identity management
software, is pleased to announce that a major European telecommunications
company will be deploying a service provider version of Intercede's edefice
electronic identity management software (edefice SP) in support of their
corporate customers.
The corporate customers will use edefice SP to register and manage individuals
who are authorised to use on-line services, and to subsequently issue, update
and revoke associated digital certificates, security tokens, smart cards and
other digital credentials. Edefice SP uses a highly scaleable architecture
capable of supporting large numbers of users in single or multi-enterprise
situations.
This contract, which includes a commitment to the value of £460,000, will be
completed within twelve months.
Intercede Chief Executive, Richard Parris said:
'We are delighted that such a major industry player has chosen to purchase
edefice SP. This further validates edefice as a platform for all aspects of
identity management including high volume service provider environments. Edefice
SP is a logical extension of our edefice family of products and demonstrates the
flexibility of our approach and our patent-pending technology.'
21 October 2002
ENQUIRIES:
Intercede Group plc Tel. 01455 558111
Richard Parris, Chairman & Chief Executive
Andrew Walker, Finance Director
College Hill Tel. 020 7457 2020
Archie Berens
Clare Warren
About Intercede
Intercede Group plc (IGP LN) (IGP.L) is a leading developer and supplier of
digital identity management software. Intercede's edeficeTM provides service
providers and end-user organizations with the tools required to quickly deploy,
maintain and manage smart cards, hardware and software tokens, biometrics, PKI
technology and other digital credentials. Intercede's customers cover a range of
industries and include ActivCard, AIB, Bank of Ireland, Barclays Bank, Datakey,
Dexia Bank, Fujitsu Services, Lloyds TSB and the NHS. For more information,
visit Intercede's home page at http://www.intercedegroup.com/ or call +44 (0)
1455 558 111.
About edeficeTM
Intercede's edeficeTM is powerful digital identity management software that
unites smart cards, tokens, biometrics, Public Key Infrastructure (PKI) and a
host of other technologies to provide cost effective identity based solutions
ranging from Corporate ID badges to complete Campus, Citizen and Health card
programs.
Edefice enabled identity solutions allow end-users to enjoy faster and more
secure access to PCs, networks, buildings and services, while providing
administrators with an easy to use web-based digital identity enrolment,
issuance and life cycle management tool.
For more information, visit the edeficeTM home page at http://www.edefice.com/
or call +44 (0) 1455 558 111.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.